MedPath

Guidewire-assisted Radial A-line in Neonate and Infant

Not Applicable
Completed
Conditions
Arterial Line
Registration Number
NCT03217019
Lead Sponsor
Seoul National University Hospital
Brief Summary

In neonate and infant, radial artery cannulation may be challenging and multiple attempts are required because of the small diameter.

The invastigators will compare the success rates of radial arterial cannulation with a guidewire-assisted technique and the direct technique in pediatric patient(\<1yr).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria
  • Pediatric patients undergoing general anesthesia with arterial cannulation (for hemodynamic monitoring or blood sampling)
Exclusion Criteria
  • Skin lesion, infection, hematoma, recent cannulation at cannulation site
  • Unstable radial pulse (d/t unstable vital sign, or arrhythmias)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
success rate at 1st attempt (%)from arterial cannulation to successful invasive BP monitoring (up to 1 hour)

successful catheter insertion after obtaining 1st blood flush in angiocatheter.

Secondary Outcome Measures
NameTimeMethod
number of total catheter used (number)from arterial cannulation to successful invasive BP monitoring (up to 1 hour)

number of total catheter used until successful cannulation.

total elapsed time (seconds)from arterial cannulation to successful invasive BP monitoring (up to 1 hour)

total time for successful cannulation.

number of total cannulation attempts (number)from arterial cannulation to successful invasive BP monitoring (up to 1 hour)

number of total attempts until successful cannulation. (1 attempt = 1 blood flush)

malfunction of arterial linefrom the start of invasive BP monitoring until the end of anesthesia (up to 1 day)

pressure monitoring, blood sampling

complicationsfrom the arterial cannulation until the end of anesthesia (up to 1 day)

hematoma, ischemia

Trial Locations

Locations (1)

Jin-Tae Kim

🇰🇷

Seoul, Korea, Republic of

Jin-Tae Kim
🇰🇷Seoul, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.